A detailed history of Bank Of America Corp transactions in Catalent, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,848,465 shares of CTLT stock, worth $111 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,848,465
Previous 589,269 213.69%
Holding current value
$111 Million
Previous $33.3 Million 212.47%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $67.5 Million - $71.8 Million
1,259,196 Added 213.69%
1,848,465 $104 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $924,913 - $1.3 Million
21,732 Added 3.83%
589,269 $33.3 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $446,626 - $646,345
-13,879 Reduced 2.39%
567,537 $25.5 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $10.8 Million - $22.8 Million
-338,399 Reduced 36.79%
581,416 $25.2 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $8.53 Million - $13.9 Million
187,785 Added 25.65%
919,815 $60.4 Million
Q4 2022

Feb 10, 2023

SELL
$41.39 - $81.0 $3.96 Million - $7.76 Million
-95,749 Reduced 11.57%
732,030 $32.9 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $25.2 Million - $39.4 Million
-348,338 Reduced 29.62%
827,779 $59.9 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $14.4 Million - $18.8 Million
164,684 Added 16.28%
1,176,117 $126 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $1.86 Million - $2.46 Million
-19,788 Reduced 1.92%
1,011,433 $112 Million
Q4 2021

Feb 08, 2022

SELL
$119.57 - $139.07 $5.55 Million - $6.46 Million
-46,427 Reduced 4.31%
1,031,221 $132 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $4.44 Million - $5.79 Million
40,705 Added 3.93%
1,077,648 $143 Million
Q2 2021

Sep 13, 2021

BUY
$100.34 - $115.69 $104 Million - $120 Million
1,036,943 New
1,036,943 $112 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.